QFT. 457 QuantiFERON -TB 2nd Generation QFT m 2 キーワーズ QFT QFT QFT QFT BCG. Kekkaku Vol. 85, No. 6: 547_552, 2010
|
|
- Kevin Cannon
- 5 years ago
- Views:
Transcription
1 Kekkaku Vol. 85, No. 6: , QFT 要旨 QFT QuantiFERON -TB 2nd Generation QFT QFT QFT QFT QFT QFT 8 QFT mm QFT m 2 キーワーズ QFT Ⅰ. 緒言 BCG ) QFT Mori 2) gold standard 89% 98% QFT QFT ke-matsumoto@city.osaka.lg.jp Received 2 Nov. 29/Accepted 8 Jan. 2
2 Table Numbers of cases interpreted as infected/ non-infected according to the criteria Criteria No. (%) Infected (any of the following) Positive QFT* Doubtful QFT* Vesicles in TST & Non-infected (any of the following) Doubtful QFT* Negative QFT* No QFT & erythema<3 mm Ⅱ. 方法 QFT ) 3 mm QFT QFT 3 mm QFT QFT QFT QFT QFT 56 ( 66.7) 7 ( 2.2) ( 3.) 84 () 8 ( 3.5) 323 ( 62.7) 74 ( 33.8) 55 () *QFT : QuantiFERON-Gold. This test is done in those with erythema of 3 mm or greater in tuberculin skin test. A doubtful QFT case is interpreted as either infected or non-infected according to the situation, e.g., as infected when there are many positives in the group. & TST: tuberculin skin test. Vesicle formation is supposed to be a very strong reaction. QFT t χ2 SPSS3.J for Windows 5% Ⅲ. 結果 QFT % 7 2.2% 3.% 84 QFT 8 3.5% QFT % 3 mm QFT % 55 Table 6 QFT 5 2 QFT mm QFT 2 mm 9.% 2 mm 5.3% 3 mm 7.5% 4 mm 2% 5 mm 33.8 % QFT 3 mm 3 mm 4 mm 4 mm QFT Table 2 5 mm QFT % % % 7 8.5% 7.7% 6 6.5% Table 2 Frequency of positive QFT according to the erythema diameter of tuberculin test TST (erythema diameter, mm QFT Result (%) ± + Indeterminate 2 (.) 8 (88.9) 48 (84.2) 2 (84.2) 58 (72.5) 44 (55.) 4 (7.) (8.3) 6 (7.5) 8 (.) (.) 3 (5.3) (7.5) 6 (2.) 27 (33.8) 2 (3.5) (.3) (75.3) 29 (8.) 57 (5.8) 3 (.8) 36 TST : tuberculin skin test
3 Infection Risk/K. Matsumoto et al % 2.% Table 3 4 χ Table 4 5 Table 5 Table m 2 Table 7 Table 3 Incidence of infection according to the place of contact with the index case Cases Known contacts Incidence of infection Workplace Hospital Clinic Nursing home Preparatory school No. (%) No. (%) No. tested Infected (%) ( 7.7) ( 8.5) ( 6.5) ( 2.2) ( 2.2) ( 65.5) ( 7.7) ( 6.6) ( 6.3) ( 3.9) (8.5) 2 ( 2.) 3 ( 7.3) 5 (3.2) ( ) 92 () 62 () (3.9) Table 4 Incidence of infection according to the related factors Factor/Category Sex of index case Male Female Age of index case Chest X-ray Lung area Unilateral Bilateral Cavity Absent Present Extent 2 3 Grade of smear positivity Duration of cough Less than 2 months 2 months or over Incidence of infection No. tested Infected (%) (3.5) 2 (5.9) 45 (3.8) 32 (2.3) 7 ( 6.) 9 ( 9.5) 65 (6.6) 22 ( 9.) 62 (7.7) 2 ( 3.6) 53 (5.6) 29 (4.7) ( 3.3) 28 (.2) 55 (8.7) 29 ( 8.4) 55 (22.4) Test p<.5 p<.5 p<. p<. p< (4.)
4 Table 5 Incidence of infection according to duration of contact Duration of contacts (hours) Incidence of infection No. tested Infected (%) P of test of linear trend of proportions=. Table 6 Incidence of infection according to area of space where contacts occurred Space of contacts (sq. meters) Incidence of infection P of test of linear trend of proportions=. 7 (2.) ( 3.8) (.6) 3 ( 8.8) 2 ( 8.3) 8 (5.4) 5 (23.) (2.7) 2 (9.4) 77 (3.9) No. tested Infected (%) (2.9) 7 (5.5) 32 (25.6) 7 ( 7.9) 5 ( 6.9) 4 ( 4.7) 79 (4.4) Ⅳ. 考察 ) QFT QFT QFT QFT QFT 4) Table 7 Odds ratios of incidence of infection according to various factors (Multiple logistic regression analysis) Factor/Category Odds ratio 95%CI Test Type of group Others Medical facility Age of index case 64 years 65 years Chest X-ray Lung area Bilateral Unilateral Cavity Present Absent Extent 2 or 3 Grade of smear positivity or + Duration of cough 2 months or over Less than 2 months Duration of contact hours 99 hours Space of contact 99 sq.meters sq.meters p<.5 p<.5 p<.
5 Infection Risk/K. Matsumoto et al ) QFT 3) 3 mm QFT 8.% 3 mm 6.% 3 mm QFT QFT 3 mm QFT 3 mm QFT QFT 3 mm QFT 2 mm QFT QFT ) G5 2 6) G % 7) 9 39 Grzybowski 8) Sepkowitz 9) Driver ) ) Grzybowski 8) Driver ) Rogers 2) 3) 4) 5) 6) 5 m 2 Ⅴ. まとめ QFT 文献,,,.. 29 ; 84 : Mori T, Sakatani M, Yamagishi F, et al.: Specific Detection of Tuberculosis Infection with an Interferon-gamma Based Assay Using New Antigens. Am J Respir Crit Care Med. 24 ; 7 : INH. 2 28, 2. 4,,,
6 ; 77 : ; 63 : ; 63 : ; 83 : Grzybowski S, Barnett GD, Styblo K : Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc. 975 ; 5 : Sepkowitz KA: How contagious is tuberculosis? Clin Infect Dis. 996 ; 23 : Driver CR, Balcewicz-Sablinska MK, Kim Z, et al.: Contact investigation in congregate settings, New York City. Int J Tuberc Lung Dis. 23 ; 7 : S ,,,.. 2 ; 75 : Rogers EFH : Epidemiology of an outbreak of tuberculosis among school children. Public Health Report. 962 ; 77 : ,,.. 27 ; 9 : ; 78 : ,,, ; 74 : ,.. 2 ; 76 : Original Article TUBERCULOSIS INFECTION BY TUBERCULIN SKIN TEST OR QuantiFERON AND RELATED FACTORS IN CONTACT INVESTIGATIO Kenji MATSUMOTO, Tomomi TATSUMI, Noriko KAMIYA, Kazuyo ARIMA, Shinichi KODA, and Satoshi HIROTA Abstract [Objective] We investigated the factors related to secondary infections in contact group investigations. [Method] From March, 28 to February, 29, a total of 457 tuberculosis (TB) notifications were reviewed by the Health Examination Committee of the Health Centers of Osaka City over indications of a contact investigation. A contact investigation was considered necessary for 92 cases with 62 contacts. For the contacts of these cases, the tuberculin skin test (TST) or / and QuantiFERON-TB 2nd Generation (QFT) was used. The contacts testing positive for QFT were classified as infected. The contacts with doubtful QFT were classified as either infected or non-infected according to the QFTpositive rate of the group as a whole. Those with blisters in TST were classified as infected. [Results] Among the total of 84 infected cases thus defined, 56 were QFT-positive, 7 were doubtful, and had blisters with TST. On the other hand, among the total of 55 uninfected cases, 8 were doubtful on the QFT test, 323 were QFT-negative and 74 were cases with TST of erythema less than 3 mm without QFT test. The relationship between characteristics of index cases and whether a contact was infected or not was as follows: Severe chest X-ray findings, sputum smear positivity, and a cough persisting for more than two months were significantly associated with infection of the contacts. The closeness of contact was also significantly related with a higher risk of infection, so that contact with an index case for more than hours, and contact in a space less than square meters were more likely to cause transmission of infection. [Conclusion] Severity of chest X-ray findings, degree of smear positivity and period of cough were confirmed to be important in judging whether investigations are necessary. The time and space of contact were also considered to be important factors. We should consider these factors comprehensively in order to decide on indications for a contact investigation. Key words: Contact examination, Infection risk, QFT, TST, Index case, Contact status Osaka City Public Health Office Correspondence to: Kenji Matsumoto, Health and Welfare Center of Nishinari Ward, Osaka City, 5 2, Kishinosato, Nishinari-ku, Osaka-shi, Osaka Japan. ( ke-matsumoto@city.osaka.lg.jp)
Osaka City is the third largest city (population
Surveillance Report Strengthened tuberculosis control programme and trend of multidrug resistant tuberculosis rate in Osaka City, Japan Akira Shimouchi, a Akihiro Ohkado, a Kenji Matsumoto, b Jun Komukai,
More informationDiagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre
Diagnostic challenges of active childhood TB in Tanzania Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre 1 Diagnosis of Childhood Tuberculosis Muheza hospital, TZ Hilleroedhospital.dk
More informationScreening of HIV-Infected Patients with IGRAs for LTBI. Background. Tuberculosis is the most prevalent in the world.
Screening of HIV-Infected Patients with IGRAs for LTBI Kentaro Sakashita, Akira Fujita, Shuji Hatakeyma Stay strong, Japan! Tokyo Metropolitan Tama Medical Center Department of Pulmonary Medicine Background
More informationPeggy Leslie-Smith, RN
Peggy Leslie-Smith, RN EMPLOYEE HEALTH DIRECTOR - AVERA TRAINING CONTENT 1. South Dakota Regulations 2. Iowa Regulations 3. Minnesota Regulations 4. Interferon Gamma Release Assay (IGRA)Testing 1 SOUTH
More informationキーワーズ ADA はじめに. 1 Table % 1) Table 2 対象と方法 CA125 2 ADA. Kekkaku Vol. 86, No. 4: 431_436, 2011
Kekkaku Vol. 6, No. 4: 43_436, 20 43 2 要旨 200 2009 3 5 2 0 67.3 5 4 2 3 ADA 2 7 INH RP 3 PZA 4 9 7 ADA キーワーズ ADA はじめに 結 果 0.04 0.5% ) 2) 対象と方法 200 2009 Table 3 5 2 0 67.3 5 4 37 6 3 3 2 2 Table 2 CRP CA25
More informationTuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director
Tuberculosis What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis? Tuberculosis, (TB) is a communicable disease caused by the Mycobacterium tuberculosis bacillus
More informationLiterature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series
Literature Overview Experience with QuantiFERON -TB Gold Health Economics Cellestis Clinical Guide series 2008 www.cellestis.com This literature overview is intended to provide healthcare professionals
More informationPreventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program
Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program Topics of Discussion TB Overview Epidemiology of TB in Oregon Annual Facility
More informationAdachi et al. SpringerPlus 2013, 2:440 a SpringerOpen Journal
Adachi et al. SpringerPlus 2013, 2:440 a SpringerOpen Journal RESEARCH Open Access Tuberculosis examination using whole blood interferon-gamma release assay among health care workers in a Japanese hospital
More informationTargeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease
Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will
More informationTB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationTB Prevention Who and How to Screen
TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection
More informationThese recommendations will remain in effect until the national shortage of PPD solution has abated.
Maryland Recommendations Regarding the National Shortage of Purified Protein Derivative (PPD) Solution; Attachment to Health Officer Memorandum National Shortages of Tubersol and Aplisol for TB Skin Testing;
More informationTuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant
Tuberculosis and Diabetes Mellitus Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Learning Objectives Understand the impact of uncontrolled diabetes mellitus (DM) on TB infection
More informationIdentifying TB co-infection : new approaches?
Identifying TB co-infection : new approaches? Charoen Chuchottaworn MD. Senior Medical Advisor, Central Chest Institute of Thailand, Department of Medical Services, MoPH Primary tuberculosis Natural history
More informationNorthwestern Polytechnic University
Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions
More informationTuberculosis Tools: A Clinical Update
Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary
More informationESCMID Online Lecture Library. by author
Tuberculosis prevention in immunodepressed patients M. Carmen Fariñas Álvarez Infectious Diseases.H.U.Marqués de Valdecilla University of Cantabria, Spain DISCLOSURES I have no potential conflicts with
More informationSelf-Study Modules on Tuberculosis
Self-Study Modules on Tuberculosis Targe te d Te s ting and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Microbiology Epidemiology Common disease presentations Diagnosis of active
More informationAudit of management of TB in HIV co-infected patients: survey of clinic arrangements
Audit of management of TB in HIV co-infected patients: survey of clinic arrangements Please complete this questionnaire if your clinic/department provides TB treatment and care for adult patients, but
More informationDisclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None
Disclosures Updates in TB for the PCP: Opportunities for Prevention None Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology, California TB Control Branch Assistant Clinical Professor, Division
More informationWhat the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB
What the Primary Physician Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Common disease presentations Diagnosis of active TB Screening
More informationLatent TB, TB and the Role of the Health Department
Latent TB, TB and the Role of the Health Department Elaine Darnall, RN, BSN, CIC TB Nurse Consultant Illinois Dept of Public Health March 21, 2018 Elaine Darnall has disclosed that there is no actual or
More informationINTENSIFIED TB CASE FINDING
INTENSIFIED TB CASE FINDING My friends call me Intensified Case Finding (ICF) I undertake regularly screening all people with, or at high risk of HIV, for symptoms of TB in health care facilities, communities
More informationUnderstanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010
Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 What is Latent TB Infection (LTBI)? Traci Hadley, RN October 5, 2010 LTBI or TB Disease? Presented by : Traci Hadley, RN
More informationAnalysis of an Interferon-Gamma Release Assay for Monitoring the Efficacy of Anti-Tuberculosis Chemotherapy
Jpn. J. Infect. Dis., 64, 133-138, 2011 Original Article Analysis of an Interferon-Gamma Release Assay for Monitoring the Efficacy of Anti-Tuberculosis Chemotherapy Kiyoko Takayanagi, Misako Aoki, Kumiko
More informationThe Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over?
The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis: Are the Days of TB Skin Tests Over? ROY F. CHEMALY, MD, MPH, FIDSA, FACP PROFESSOR OF MEDICINE DIRECTOR, INFECTION CONTROL SECTION
More informationDiagnosis Latent Tuberculosis. Disclosures. Case
Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures
More informationMechanisms Involved the Continuation of Exercise in Patients with Type Diabetes Mellitus.
原 著 Mechanisms Involved the Continuation of Exercise in Patients with Type Diabetes Mellitus. Matsumi Yamazaki Michiko Inagaki Key Words diabetes, exercise, patient education Ⅰ. はじめに, QOL % School of Nursing,
More informationInterpretation of TST & IGRA results. Objectives
Interpretation of TST & IGRA results Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver Objectives
More informationLATENT TUBERCULOSIS. Robert F. Tyree, MD
LATENT TUBERCULOSIS Robert F. Tyree, MD 1 YK TB OFFICERS Ron Bowerman Elizabeth Roll Mien Chyi (Pediatrics) Cindi Mondesir (Pediatrics) The new guys: Philip Johnson Robert Tyree 2009 CDC TB CASE DEFINITION
More informationTUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of
TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of Health and Mental Hygiene TODAY S PRESENTATION Epidemiology
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationApproaches to LTBI Diagnosis
Approaches to LTBI Diagnosis Focus on LTBI October 8 th, 2018 Michelle Haas, M.D. Associate Director Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES I have no disclosures or conflicts
More informationCooperation. Tuberculosis Panel on Tips from the Field. Introductions. Katie Dickerson, RN. David Miller, RN. Moni Muraki
Tuberculosis Panel on Tips from the Field Lana Kay Tyer, RN MSN TB Nurse Consultant Department of Health Introductions Katie Dickerson, RN David Miller, RN Moni Muraki Cooperation 1 COOPERATION Long-term
More informationはじめに 対象と方法 39: , 2017 SAH 183 WFNS
39:107 原 著 39: 107 112, 2017 1 2 1 1 1 1 要旨 SAH 2010 1 2013 12 SAH 253 183 64 70 WFNS I III 72.7 Fisher CT 3 86.3 19.9 16.6 GR MD 73.2 73.1 80 WFNS Key words: subarachnoid hemorrhage, prognosis, rate of
More informationTesting for TB. Bart Van Berckelaer Territory Manager Benelux. Subtitle
Testing for TB Bart Van Berckelaer Territory Manager Benelux Subtitle Agenda TB infection pathway TB immunisation Testing options Pre lab considerations of the whole blood ELISA test The T-SPOT.TB test
More informationA look at medical factors that increase the risk for TB disease
A look at medical factors that increase the risk for TB disease Mark Lobato, MD New England TB Consultant Division of Tuberculosis Elimination CDC Overview The spectrum of M. tuberculosis infection Immune
More informationNew Standards for an Old Disease:
New Standards for an Old Disease: Practical Implications of the TB Standards TB Prevention and Control Saskatchewan September 16, 2015 Practical Implications of the TB Standards Learning Objectives At
More information2017/2018 Annual Volunteer Tuberculosis Notice
Lewis Center for Educational Research Academy for Academic Excellence Norton Science and Language Academy Business Offices 17500 Mana Road Apple Valley, CA 92307 E-mail: hr@lcer.org 760-946-5414 Fax 760-946-9193
More information결핵노출접촉자감염관리 서울아산병원감염내과 김성한
결핵노출접촉자감염관리 서울아산병원감염내과 김성한 TB incidence (2012) TB incidence South Korea 108 China 73 Taiwan 68 Portucal 26 Japan 19 Spain 14 US 3.6 * unit- per 100,000 population Adapted from WHO Adapted from WHO Emerg
More informationTuberculosis Intensive
Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Childhood Tuberculosis Kim Smith, MD, MPH April 6, 2012 Kim Smith, MD, MPH has the following disclosures to make: No conflict of interests No relevant
More informationFLORIDA DEPARTMENT OF JUVENILE JUSTICE DETENTION SERVICES FACILITY MEDICAL POLICIES
FLORIDA DEPARTMENT OF JUVENILE JUSTICE DETENTION SERVICES FACILITY MEDICAL POLICIES Superintendent Signature Designated Health Authority Signature Effective Date: November 1, 2016 Subject: TUBERCULOSIS
More informationLatent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers
Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers Who Should Be Screened for Latent Tuberculosis Infection (LTBI)?... 2 What tests are used to screen for LTBI?... 2 How
More informationUC DavisTB Screening Requirement: How to submit your TB Health Assessment Form
UC DavisTB Screening Requirement: How to submit your TB Health Assessment Form Step 1 If after completing the TB Risk Screening you are found to be at high risk, you must complete the Tuberculosis (TB)
More informationDiagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017
Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has
More informationLet s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Madhukar Pai, MD, PhD Author and Series Editor Camilla Rodrigues, MD co-author Abstract Most individuals who get exposed
More informationAuthor's response to reviews
Author's response to reviews Title: Contribution of Interferon Gamma Release Assays testing to the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Patients: A comparison of QuantiFERON Gold
More informationTB Intensive San Antonio, Texas
TB Intensive San Antonio, Texas August 2-5, 2011 Pediatric TB Jeffrey Starke, MD August 5, 2011 Jeffrey Starke, MD has the following disclosures to make: Is on a data safety monitoring board for Hoffman
More informationDetection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges
Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures
More informationTransmission of DS-TB and MDR-TB. C. Robert Horsburgh, Jr. Boston University School of Public Health
Transmission of DS-TB and MDR-TB C. Robert Horsburgh, Jr. Boston University School of Public Health Outline Epidemiologic factors in transmission Ability of the transmitter to transmit Susceptibility of
More informationContact Investigation
Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period
More informationTherapy for Latent Tuberculosis Infection
Screening and Treatment of LTBI in TB Control in the US Margarita Elsa Villarino MD MPH Division of TB Elimination, CDC April 14, 2004 TB Prevention and Control in the United States The fundamental strategies
More informationTB Contact Investigation Basics
TB Nurse Case Management Lisle, Illinois April 27-28, 28 2010 TB Contact Investigation Basics Carrie Storrs, RN April 28, 2010 Contact Investigation Carrie Storrs TB Program Illinois Department of Public
More informationTuberculosis 6/7/2018. Objectives. What is Tuberculosis?
Tuberculosis Understanding, Investigating, Eliminating Jeff Maupin, RN Tuberculosis Control Nurse Sedgwick County Division of Health Objectives At the conclusion of this presentation, you will be able
More informationATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS
1. QUESTION Is it required to submit the Annual Report of TB Testing in Schools Form (TB-57) to the New Jersey Department of Health,? NO. The TB-57 form is completed by the school nurse and kept on-site
More informationTB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014
TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014 Catalina Navarro, BSN, RN has the following disclosures to make: No conflict of interests No relevant financial relationships with
More informationPrevalence of Latent Tuberculosis Infection among Health Care Workers in South Korea: A Multicenter Study
ORIGINAL ARTICLE http://dx.doi.org/10.4046/trd.2013.75.1.18 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2013;75:18-24 Prevalence of Latent Tuberculosis Infection among Health Care Workers
More informationRESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS
Southeast Asian J Trop Med Public Health RESEARCH NOTE QUANTIFERON -TB GOLD IN-TUBE TEST FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION AMONG CLINICAL-YEAR THAI MEDICAL STUDENTS Benjawan Phetsuksiri 1, Somchai
More informationCOFM Immunization Policy 2016
COFM Immunization Policy 2016 Council of Ontario Faculties of Medicine June 2016 COUNCIL OF ONTARIO FACULTIES OF MEDICINE An affiliate of the Council of Ontario Universities COFM Immunization Policy 2016
More informationTB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012
TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release
More informationWhat you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014
What you need to know about diagnosing and treating TB: a preventable, fatal disease Bob Belknap M.D. Denver Public Health November 2014 The Critical First Step Consider TB in the Differential 1. Risks
More informationSummary of Immunization Options
Student Health Services 30 Bee Street Suite 102 Charleston, SC 29425 Telephone 843-792-3664 Fax 843-792-2569 Visiting Students Immunization Requirements All MUSC students, including visiting students,
More informationBarbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and Infectious Disease UT Health Northeast
Practical Aspects for Using the Interferon Gamma Release Assay (IGRA) Test Live Webinar July 14, 2017 Barbara J Seaworth MD Medical Director, Heartland National TB Center Professor, Internal Medicine and
More information10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose
Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population
More informationTuberculosis Update. Topics to be Addressed
Tuberculosis Update Robert M. Jasmer, M.D. University of California, San Francisco TB Control Section, San Francisco Department of Public Health Topics to be Addressed TB in the USA Screening recommendations
More informationTuberculosis (TB) Fundamentals for School Nurses
Tuberculosis (TB) Fundamentals for School Nurses June 9, 2015 Kristin Gall, RN, MSN/Pat Infield, RN-TB Program Manager Marsha Carlson, RN, BSN Two Rivers Public Health Department Nebraska Department of
More informationTUBERCULOSIS. Pathogenesis and Transmission
TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are
More informationTUBERCULOSIS CONTACT INVESTIGATION
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used
More informationPREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal
PREVENTION OF TUBERCULOSIS Dr Amitesh Aggarwal 25 to 50 % of persons exposed to intimate contact with active PTB - latent infection with TB. Exposure to index case for 12 hours - high risk of infection.
More informationDiagnosis of tuberculosis in children
Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence
More informationCUSOM Student Health Immunization Requirements
CUSOM Student Health Immunization Requirements Regulatory and legislative authorities require that students demonstrate immunization, immunity and/or protection from multiple contagious diseases before
More informationDiagnosis and Medical Case Management of Latent TB. Bryan Rock, MD April 27, 2010
TB Nurse Case Management Lisle, Illinois April 27-28, 28 2010 Diagnosis and Medical Case Management of Latent TB Infection Bryan Rock, MD April 27, 2010 DIAGNOSIS AND MANAGEMENT OF LATENT TUBERCULOSIS
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationUvA-DARE (Digital Academic Repository) Tuberculosis case finding in South Africa Claassens, M.M. Link to publication
UvA-DARE (Digital Academic Repository) Tuberculosis case finding in South Africa Claassens, M.M. Link to publication Citation for published version (APA): Claassens, M. M. (2013). Tuberculosis case finding
More informationThe Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers
ORIGINAL ARTICLE The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers Masaki Tanabe 1, Akiko Nakamura 1, Akie Arai 1, Daisuke Yamasaki
More informationMaking the Diagnosis of Tuberculosis
Making the Diagnosis of Tuberculosis Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Testing for TB Infection Targeted Testing: Key Points Test only if plan for ensuring treatment De-emphasizes
More informationClinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis*
CHEST Clinical Utility of the QuantiFERON -2G Test for Elderly Patients With Active Tuberculosis* Yoshihiro Kobashi, MD, PhD; Keiji Mouri, MD; Shinich Yagi, MD; Yasushi Obase, MD, PhD; Naoyuki Miyashita,
More information2nd. Comparison of Self-stretch Methods for Secondary Internal Rotation Limitation in Injured Throwing Shoulders: Evaluation of the Direct Effect
31 1 13 17 2016 原著 2nd Comparison of Self-stretch Methods for Secondary Internal Rotation Limitation in Injured Throwing Shoulders: Evaluation of the Direct Effect 1,2) 1) 1) 3) 3) KENTARO KAWAI, RPT,
More informationJournal of Epidemiology Vol. 15, No. 2 March 2005
Journal of Epidemiology Vol. 5, No. March 5 The incidence of tuberculosis in Japan still continues to be higher than that in other developed countries. In in Japan, the annual notification rate of new
More informationYakima Health District BULLETIN
Yakima Health District BULLETIN Summary Volume 13, Issue 1 February, 2014 Tuberculosis in Yakima County The rate of active tuberculosis (TB) in Yakima County has declined by about two-thirds over the past
More informationRevised Technical Instructions for Civil Surgeons. October 9, 2018
Revised Technical Instructions for Civil Surgeons October 9, 2018 Speakers Joanna Regan Centers for Disease Control and Prevention Shereen Katrak California Department of Public Health Pennan Barry California
More informationSanta Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, 2014
Guidelines to Revisions to the School Mandate and Requirements 1) What are the tuberculosis (TB) screening requirements for school entrance in Santa Clara County? Students must undergo a TB risk assessment
More informationDirector, University Health Services. Medical Director
March 2011 Issued, Revised, or Reviewed) Approved by: Office of Student Affairs Director, University Health Services Medical Director SUBJECT: SCREENING OF HEALTH SERVICES STAFF FOR TUBERCULOSIS POLICY
More informationORIGINAL ARTICLE. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
ERJ Express. Published on July 25, 2007 as doi: 10.1183/09031936.00040007 ORIGINAL ARTICLE Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Yoshihiro Kobashi, Keiji Mouri, Yasushi
More informationGuidance for Identifying Risk Factors for Mycobacterium tuberculosis (MTB) During Evaluation of Potential Living Kidney Donors
Summary and Goals On November 13, 2012, the OPTN/UNOS Board of Directors approved a requirement that all potential living kidney donors undergo evaluation for infection with Mycobacterium tuberculosis
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationManagement of Pediatric Tuberculosis in New Jersey
Management of Pediatric Tuberculosis in New Jersey Helen Aguila, MD NJMS Global TB Institute December 15, 2011 This presentation is in part adapted from Pediatric Tuberculosis by Ann Loeffler, MD : Francis
More informationAPSR RESPIRATORY UPDATES
APSR RESPIRATORY UPDATES Volume 5, Issue 2 Newsletter Date: February 2013 APSR EDUCATION PUBLICATION Inside this issue: Tuberculosis Multidrug-resistant pulmonary tuberculosis treatment regimens and patient
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 Interferon Gamma Release Assays Lisa Armitige, MD, PhD November 12, 2014 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of
More informationTB Contact Investigation
Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.
More informationDiagnosis and Medical Management of Latent TB Infection
Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,
More information2016 OPAM Mid-Year Educational Conference, Sponsored by AOCOPM Sunday, March 13, 2016
Learning Objectives Tuberculosis Case Discussions: Evaluation for Tuberculosis Infection Melissa C. Overman, DO, MPH, CHES, FAOCOPM Describe appropriate technique for TST placement, reading and interpretation
More informationTuberculosis. WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED
Tuberculosis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED Acknowledgments COL Paul Keiser LTC James E. Moon LTC Jaime Mancuso LTC Anjali Kunz MAJ Kristopher Paolino MAJ Leyi
More informationTB Intensive Tyler, Texas December 2-4, 2008
TB Intensive Tyler, Texas December 2-4, 2008 Interferon Gamma Releasing Assays: Diagnosing TB in the 21 st Century Peter Barnes, MD December 2, 2008 TOPICS Use of interferon-gamma release assays (IGRAs)
More informationDiagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers
REVIEW http://dx.doi.org/10.4046/trd.2016.79.3.127 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2016;79:127-133 Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers
More informationPediatric TB Lisa Armitige, MD, PhD September 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.
More information